Literature DB >> 22008499

An atypical case of Brugada syndrome.

Almpanis Georgios1, Servos Georgios, Tragotsalou Nikolitsa, Koutsogiannou Persefoni, Mazarakis Andreas.   

Abstract

Polymorphic ventricular tachycardia and ventricular fibrillation are the most common arrhythmias in Brugada syndrome causing syncope or sudden death. Sustained monomorphic ventricular tachycardias are rare in this context. We report of a patient with syncopal episodes due to episodes of sustained ventricular tachycardia, where a Type-I Brugada pattern was revealed after pharmacological provocation with procainamide. ©2011, Wiley Periodicals, Inc.

Entities:  

Mesh：

Year:  2011        PMID： 22008499      PMCID： PMC6932403          DOI： 10.1111/j.1542-474X.2011.00457.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN： 1082-720X            Impact factor:   1.468


  10 in total

1.  A sodium channel pore mutation causing Brugada syndrome.

Authors:  Arnold E Pfahnl; Prakash C Viswanathan; Raul Weiss; Lijuan L Shang; Shamarendra Sanyal; Vladimir Shusterman; Cari Kornblit; Barry London; Samuel C Dudley
Journal:  Heart Rhythm       Date:  2006-09-28       Impact factor: 6.343

2.  Genetic basis of Brugada syndrome.

Authors:  Charles Antzelevitch
Journal:  Heart Rhythm       Date:  2007-03-23       Impact factor: 6.343

3.  Clinical, genetic, and biophysical characterization of SCN5A mutations associated with atrioventricular conduction block.

Authors:  Dao W Wang; Prakash C Viswanathan; Jeffrey R Balser; Alfred L George; D Woodrow Benson
Journal:  Circulation       Date:  2002-01-22       Impact factor: 29.690

Review 4.  Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association.

Authors:  Charles Antzelevitch; Pedro Brugada; Martin Borggrefe; Josep Brugada; Ramon Brugada; Domenico Corrado; Ihor Gussak; Herve LeMarec; Koonlawee Nademanee; Andres Ricardo Perez Riera; Wataru Shimizu; Eric Schulze-Bahr; Hanno Tan; Arthur Wilde
Journal:  Circulation       Date:  2005-01-17       Impact factor: 29.690

5.  Electropharmacology of amiodarone therapy initiation. Time courses of onset of electrophysiologic and antiarrhythmic effects.

Authors:  L B Mitchell; D G Wyse; A M Gillis; H J Duff
Journal:  Circulation       Date:  1989-07       Impact factor: 29.690

6.  Spontaneous sustained monomorphic ventricular tachycardia after administration of ajmaline in a patient with Brugada syndrome.

Authors:  E Pinar Bermúdez; A García-Alberola; J Martínez Sánchez; J J Sánchez Muñoz; M Valdés Chávarri
Journal:  Pacing Clin Electrophysiol       Date:  2000-03       Impact factor: 1.976

7.  Clinical and molecular heterogeneity in the Brugada syndrome: a novel gene locus on chromosome 3.

Authors:  Raul Weiss; M Michael Barmada; Tuduy Nguyen; Jolene S Seibel; Doris Cavlovich; Cari A Kornblit; Adam Angelilli; Flordeliza Villanueva; Dennis M McNamara; Barry London
Journal:  Circulation       Date:  2002-02-12       Impact factor: 29.690

8.  Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation.

Authors:  G X Yan; C Antzelevitch
Journal:  Circulation       Date:  1999-10-12       Impact factor: 29.690

9.  Monomorphic ventricular tachycardia in 'Brugada syndrome': clinical case and literature review.

Authors:  Giuseppe Allocca; Alessandro Proclemer; Gaetano Nucifora; Erica Dall'Armellina; Luca Rebellato
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2008-08       Impact factor: 2.160

10.  Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report.

Authors:  P Brugada; J Brugada
Journal:  J Am Coll Cardiol       Date:  1992-11-15       Impact factor: 24.094
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.